Children who suffer from the rare genetic disease, Progeria, may have a chance at a longer life. The drug, Lonafarnib, which was originally created for cancer patients, has been used in a test to treat children who have Progeria.
Children who suffer from the rare genetic disease, Progeria, may have a chance at a longer life. The drug, Lonafarnib, which was originally created for cancer patients, has been used in a test to treat children who have Progeria.